Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
CNBC· 3 小時前Pfizer's twice-daily version of its experimental weight loss pill has now joined a long ...
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
CNBC· 1 日前... on Friday said it would stop developing the twice-daily version of its experimental weight ...
Pfizer Pulls Experimental Twice-Daily Weight Loss Drug—Shares Slide 6% To Multiyear Low
Forbes· 1 日前... announced Friday it won’t move forward with trials for a twice-daily regimen of its weight ...
‘The Golden Bachelor’s’ Reputation Tarnished Ahead Of Season Finale
Forbes· 2 日前The Golden Bachelor finale is still hours away, but fans of the series’ freshman season are ...
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, ...
CNBC· 5 日前The blockbuster diabetes drug Mounjaro is more effective for weight loss than another highly ...
WBO President Criticizes WBA And WBC Decision To Create Extra Heavyweight Division
telecomasia.net· 3 小時前World Boxing Organization (WBO) president Paco Valcarcel said that the decision of the WBA and ...
Suicide Risk From Weight-Loss Drugs Prompts More EU Questions
Bloomberg· 1 日前The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and ...
Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly
CNBC· 22 小時前Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and ...
Weight-Loss Drugs Are a Gold Mine, and Just as Elusive
Bloomberg· 23 小時前On Friday, Pfizer Inc. announced that it’s dropping development of an experimental weight-loss ...
China’s Economic Heft Sinks for First Time in Three Decades
Bloomberg· 5 小時前For most of us, weight loss is a positive. New analysis showing that China’s global heft has ...
